美國Helixis
Helixis公司成立于2007年,由美國加州理工學院生物學家,諾貝爾獎獲得者David Baltimore博士和電機工程專家Axel Scherer博士共同創立。總部設在美國的加利福尼亞州。
David Baltimore博士: 世界上最有影響的生物學家之一, 34歲獲得麻省理工學院生物學教授,36歲當選美國科學院院士,37歲因為在RNA病毒研究方面的突出貢獻獲得諾貝爾生理醫學獎,自1997‐2006年,擔任加州理工學院的院長。
Axel Scherer博士: 世界著名光子與微細加工專家,1993年開辦加州理工學院納米加工研究所,創立了光學晶體學,致力于半導體微加工技術研究,并應用于光子學和生物學設備,在世界光電子領域處于領先地位。2001年合作創辦了Luxtera公司,在新一代光子通訊技術方面,具有大量創新性專利,超越了IBM,Intel等公司,是SUN Microsystem (太陽微系統公司),Philips的技術合作伙伴。
Helixis, headquartered in Carlsbad, California, develops innovative nucleic acid tools for research and clinical diagnostics applications. The privately held company was founded in 2007 through a unique collaboration between molecular biologists and engineers in the labs of Nobel Laureate David Baltimore, Ph.D., and Axel Scherer, Ph.D., at the California Institute of Technology. Helixis is currently developing a new generation of high-performance, low-cost, real time polymerase chain reaction (qPCR) systems.
At Helixis, we are developing advanced nucleic acid analysis tools for the research scientist and clinical applications. Combining technology from the labs of David Baltimore and Axel Scherer at the California Institute of Technology (Caltech) with insights from life-sciences researchers around the world, we are building next-generation real-time polymerase chain reaction (PCR) solutions that overcome limitations and change the rules.